Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Billion by 2028 exhibit a CAGR of 5.2%

The Antibiotic Susceptibility Testing Market generated US$ 3 billion in revenue in 2022. The market will be worth US$ 4.05 billion and have expanded at a CAGR of 5.2% by 2028.

Demand for antibiotic susceptibility testing is being driven up by the increasing usage of antibiotics to treat even the most prevalent health issues (AST). The performance of the antibiotic susceptibility testing market is being strengthened by increasing government funding for microbial and antibiotic susceptibility testing research and continually improving PPP results in terms of improved screening and evaluation of antibiotics.

CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

Sample Copy of Report @

https://www.futuremarketinsights.com/reports/sample/rep-gb-8574

A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

• Infectious diseases, prevailing at a high pace
• Increasing rate and tenure of hospitalization
• Growing significance of early diagnostics
• Soaring research interests in microbial susceptibility testing
• Improving funding scenario for research, driven by governments & private bodies
• Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028, expanding at a CAGR of 5.2%

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens.

Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include Genmark Diagnostics’ ePLEX Blood Culture ID Panel, Biomerieux’s BioFire FilmArray, and Luminex Corp.’s Verigene Bloodstream Infection Panel.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8574

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market.

A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy.

Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years.

Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8574

This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Key Segments Of Antibiotic Susceptibility Testing Industry SurveyAntibiotic Susceptibility Testing Market by Product:

• Instruments
  • Automated Broth Microdilution Systems
  • Manual Broth Microdilution Systems
  • Semi-automated Broth Microdilution Systems
• Software & Services
  • Image & Analysis Software
  • Installation Services
• Kits & Reagents

Antibiotic Susceptibility Testing Market by Application:

• Sepsis
• Respiratory Infections
• Gastrointestinal Infections
• Meningitis & Encephalitis
• Endocarditis
• Others

Antibiotic Susceptibility Testing Market by End User:

• Diagnostic Laboratories
• Hospitals
• Research Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 07-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs